Tomorrow, I’m entering a position in Pfizer Inc. (NYSE: PFE)—a globally recognized pharmaceutical giant with strong fundamentals and an attractive technical setup.
Pfizer maintains a solid revenue base, reporting $62.46 billion in total revenue in the last fiscal year. Despite recent fluctuations, its profitability remains intact, with a gross profit of $45.15 billion. The company continues to invest in drug innovation and strategic acquisitions, ensuring long-term growth.
Pfizer is a consistent dividend payer, making it an attractive choice for income-focused investors. Its dividend yield remains competitive, reinforcing its appeal as a long-term hold.
I see strong upside potential — both technically and fundamentally. Now is the perfect time to enter.
交易進行
I bought 200 shares today (225 total) and I bought 10 options!
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。